It’s a multi-billion-dollar industry that the agency says poses a growing risk to patients because of potentially inaccurate results. the proposed rule would formally bring thousands of tests performed in large laboratories under FDA oversight.
It’s a multi-billion-dollar industry that the agency says poses a growing risk to patients because of potentially inaccurate results. the proposed rule would formally bring thousands of tests performed in large laboratories under FDA oversight.